Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- LQDT -17.4%, FRED -11.6%, VEEV -4.6%, VNET -2.6%, HD -2.1% (guidance), RH -1.8%, HQY -1.4%
Other news:
- TROX -21.5% (FTC merger challenge alleging that combining Tronox and Cristal would reduce competition; administrative trial is scheduled to begin on May 8, 2018), CUR -15.2% (after closing near highs -- up 175%)
- BBG -12.6% (prices 21 mln shares of common stock)
- VKTX -12% ( intends to offer shares of common stock in underwritten public offering)
- EDIT -4.2% (prices underwritten offering of 1.97 mln shares of its common stock)
- GWPH -2.1% (to sell $225 mln of American Depositary Shares representing ordinary shares an underwritten U.S. public offering)
- TRHC -2.1% (prices offering by co and selling shareholders of 3 mln shares of common stock at $27.50 per share)
- EIX -1.6% (modestly rebounding; has been periodically issuing updates on outages and wildfires)
- RVNC -1.3% (Revance Therapeutics proposed offering of $175 mln in common stock and 600K shares by selling stockholders; also files mixed securities shelf offering), KSHB -0.9% ( files for $100 mln mixed securities shelf offering)
Analyst comments:
- PDCO -3.7% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
- VNTR -3.7% (downgraded to Neutral from Buy at Goldman)
- HSIC -3% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
- SNAP -2.4% (initiated with a Underperform at Evercore ISI; tgt $7)
- EIX -1.6% (downgraded to Neutral from Buy at Mizuho)